Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease: Survival Estimates From the EMPA-REG OUTCOME Trial

被引：32
|
作者：
Claggett, Brian [1 ]
Lachin, John M. [2 ]
Hantel, Stefan [3 ]
Fitchett, David [4 ,5 ]
Inzucchi, Silvio E. [6 ]
Woerle, Hans J. [7 ]
George, Jyothis T. [7 ]
Zinman, Bernard [5 ,8 ]
机构：
[1] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA
[2] George Washington Univ, Biostat Ctr, Rockville, MD USA
[3] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[4] St Michaels Hosp, Div Cardiol, Toronto, ON, Canada
[5] Univ Toronto, Toronto, ON, Canada
[6] Yale Univ, Endocrinol Sect, Sch Med, New Haven, CT USA
[7] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[8] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
来源：
CIRCULATION | 2018年 / 138卷 / 15期
关键词：
cardiovascular diseases; diabetes mellitus; empagliflozin;
D O I：
10.1161/CIRCULATIONAHA.118.033810
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1599 / 1601
页数：3
相关论文
共 50 条
  • [41] Use of loop diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA-REG OUTCOME trial
    Pellicori, P.
    Fitchett, D.
    Kosiborod, M.
    Ofstad, A. P.
    Seman, L.
    Zinman, B.
    Zwiener, I.
    Wanner, C.
    George, J. T.
    Inzucchi, S. E.
    Testani, J.
    Cleland, J. G. F.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S444 - S445
  • [42] Early benefits of empagliflozin in patients with type 2 diabetes with heart failure are not offset by increased adverse events: results from the EMPA-REG OUTCOME trial
    Pellicori, P.
    Ofstad, A. Pernille
    Fitchett, D.
    Zeller, C.
    Wanner, C.
    George, J.
    Zinman, B.
    Brueckmann, M.
    Lindenfeld, J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1586 - 1586
  • [43] Empagliflozin and progression of chronic kidney disease in type 2 diabetes complicated by nephrotic-range proteinuria: insights from the EMPA-REG OUTCOME trial
    Ruggenenti, P.
    Inzucchi, S.
    Zinman, B.
    Hantel, S.
    Koitka-Weber, A.
    von Eynatten, M.
    Wanner, C.
    DIABETOLOGIA, 2018, 61 : S508 - S508
  • [44] Empagliflozin Reduces Mortality and Hospitalization for Heart Failure in Patients With Type 2 Diabetes and Peripheral Artery Disease: A Sub-Analysis of the EMPA-REG OUTCOME Trial
    Verma, Subodh
    Mazer, C. D.
    Fitchett, David
    Inzucchi, Silvio E.
    George, Jyothis T.
    Pfarr, Egon
    Woerle, Hans J.
    Zinman, Bernard
    CIRCULATION, 2017, 136 (24) : E456 - E456
  • [45] Empagliflozin reduces mortality in patients with type 2 diabetes and a history of left ventricular hypertrophy: a sub-analysis of the EMPA-REG OUTCOME trial
    Verma, S.
    Mazer, D. C.
    Bhatt, D. L.
    Raj, S. R.
    Yan, A. T.
    Verma, A.
    Ferrannini, E.
    Simons, G.
    Lee, J.
    Zinman, B.
    George, J. T.
    Fitchett, D.
    EUROPEAN HEART JOURNAL, 2018, 39 : 399 - 399
  • [46] Short-Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial
    Waijer, Simke W.
    Xie, Di
    Inzucchi, Silvio E.
    Zinman, Bernard
    Koitka-Weber, Audrey
    Mattheus, Michaela
    von Eynatten, Maximillian
    Inker, Lesley A.
    Wanner, Christoph
    Heerspink, Hiddo J. L.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (18):
  • [47] THE INFLUENCE OF MICROVASCULAR DISEASE ON CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES: A POST HOC ANALYSIS OF EMPA-REG OUTCOME
    Verma, Subodh
    Wanner, Christoph
    Zwiener, Isabella
    Ofstad, Anne Pernille
    George, Jyothis T.
    Fitchett, David
    Zinman, Bernard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 2037 - 2037
  • [48] THE INFLUENCE OF MICROVASCULAR DISEASE ON CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES: A POST HOC ANALYSIS OF EMPA-REG OUTCOME
    Verma, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E193 - E193
  • [49] THE ASSOCIATION BETWEEN POLYVASCULAR DISEASE AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES: A SUB-ANALYSIS OF EMPA-REG OUTCOME
    Verma, Subodh
    Mazer, C. David
    Inzucchi, Silvio E.
    Wanner, Christoph
    Ofstad, Anne Pernille
    Johansen, Odd Erik
    Zwiener, Isabella
    George, Jyothis T.
    Butler, Javed
    Zinman, Bernard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1859 - 1859
  • [50] Cardiovascular outcomes trial data from EMPA-REG OUTCOME, CAROLINA and CARMELINA: Assessment of a novel staging system for type 2 diabetes
    Dar, Moahad S.
    Wanner, Christoph
    Marx, Nikolaus
    Ofstad, Anne Pernille
    Mattheus, Michaela
    Kaspers, Stefan
    Beg, Sami A.
    DIABETES OBESITY & METABOLISM, 2023, 25 (05): : 1372 - 1384
12345